期刊文献+

支气管肺炎患儿治疗前后血清hs-CRP、IGF-Ⅱ和IL-6水平检测的临床意义 被引量:10

Clinical significance of determination of changes of serum hs-CRP,IGF-Ⅱ and IL-6 levels after treatment in children with bronchopneumonia.
下载PDF
导出
摘要 目的探讨支气管肺炎患儿治疗前后血清超敏C-反应蛋白(hs-CRP)、胰岛素样生长因子-Ⅱ(IGF-Ⅱ)和白细胞介素6(IL-6)水平检测的临床意义。方法应用放射免疫分析法和免疫比浊法对34例支气管肺炎患儿进行了治疗前后血清hs-CRP、IGF-Ⅱ和IL-6水平检测,并与30例正常健康儿童作比较。结果在治疗前,支气管肺炎患儿血清hs-CRP、IGF-Ⅱ和IL-6水平均非常显著地高于正常人组(P<0.01),经治疗一周后与正常儿童组比较无显著性差异(P>0.05)。对支气管肺炎患儿血清hs-CRP水平、血清IGF-Ⅱ和IL-6水平进行了相关分析,结果呈明显正相关。结论检测支气管肺炎患儿血清中hs-CRP、IGF-Ⅱ和IL-6水平的变化对疾病的诊断、治疗和预后判断均有重要的临床价值。 Objective To explore clinical significance of changes of serum high - sensitivity C - rective protein( hs - CRP), insulin - like growth factor-Ⅱ ( IGF -Ⅱ ) and interleukin - 6 ( IL - 6) levels after treatment in children with bronehopneumonia. Methods Serum hs - CRP was detected with immunoturbidimetry and IGF-Ⅱ and IL - 6 were detected with radio immunoassay before and after treatment in 34 children with bronchopneumonia. The results were compared with the levels of hs - CRP, IGF-Ⅱ and IL - 6 in 30 healthy children. Results Before treatment, serum hs - CRP, IGF-Ⅱ, and IL -6 levels in patients were significantly higher than those in controls( P 〈0. 01 ). After one week treatment, las - CRP, IGF-Ⅱ and IL - 6 levels were not significantly differem from those in control ( P 〉 0.05 ). To analysis bronchial pneumonia on serum levels of las - CRP, IGF-Ⅱ , IL - 6, the results showed significant positive correlation. Conclusion Determination of serum hs - CRP, IGF -Ⅱ and IL -6 levels in children with bronchopneumonia was important for diagnosis and outcome prediction.
作者 张翠红 夏雯
出处 《临床和实验医学杂志》 2009年第12期14-15,共2页 Journal of Clinical and Experimental Medicine
关键词 支气管肺炎 超敏C-反应蛋白(hs—CRP) 胰岛素样生长因子-Ⅱ(IGF-Ⅱ) 白细胞介素-6(IL-6) Bronchopneumonia High - sensitivity C - reetive protein( hs - CRP) Insulin - like growth factor -Ⅱ ( IGF - rl ) Interleukin - 6( IL - 6 )
  • 相关文献

参考文献3

二级参考文献31

  • 1Hopkins PN,Williams RR. A survey of 246 suggested coronary risk factors[J]. Atherosclerosis, 1981,40:1-52.
  • 2EUROASPIRE:a Europan Society of Cardiology survery of secondary prevention of coronary heart disease: principal results[J]. Eur Heart J, 1997,18:1569-1582.
  • 3Ross R. Atheroslerosis-an inflammatory disease[J]. N Engl J Med, 1999,340:115-126.
  • 4Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis [ J]. Circulation, 2001,103 :1194-1197.
  • 5Nakagomi A, Freedman SB, Geczy CL. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex,and hormone replacement treatment [J]. Circulation, 2000,101:1785-1791.
  • 6Penn MS, Topol EJ. Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling[J]. Cir Res, 2001,89:1-2.
  • 7Yasojima K,Schwab C, McGeer EG, et al. Generation of C-Reactive protein and complement components in atheroscle-rotic plaques[J]. Am J Pathol,2001,158 : 1039-1051.
  • 8Tomai F,Crea F,Gaspardone A, et al. Unstable angina and elevated C-reactive protein levels predict enhanced vasore-activity of the culprit lesion [J]. Circulation, 2001, 104 :1471-1476.
  • 9Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells[J].Circulation, 2000,102 : 2165-2168.
  • 10Nakajima T,Schulte S,Warrington K J, et al. T-cell-media-ted lysis of endothelial cells in acute coronary syndromes[J]. Circulation, 2002,105:570-575.

共引文献77

同被引文献77

引证文献10

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部